Heart Pump Still Promising After Missing Endpoint

ACC 2011 — NEW ORLEANS -- A trial comparing the Impella heart pump and an intra-aortic balloon pump for hemodynamic support during high-risk percutaneous coronary intervention failed to meet its primary endpoint -- but researchers say the device still holds some promise.

Keywords: ACC Annual Scientific Session

< Back to Listings